Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 1Gynecologic 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Peripheral Sensory Neuropathy 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Multiple Myeloma 1Infertility, Female 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Interventional × Acetylcarnitine × Clear all
NCT05767515 2026-02-09

PCOS

Khyber Medical University Peshawar

Phase NA Completed
120 enrolled

Infertility, Female, Polycystic Ovary Syndrome

NCT00581919 2019-12-13

Ph 2 Bortezomib, Dexamethasone, + Doxorubicin With ALCAR for Previously Treated Multiple Myeloma

University of Wisconsin, Madison

Phase 2 Completed
32 enrolled 8 charts
Plasma cell

Multiple Myeloma

NCT00751205 2014-10-28

Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)

Bayer

Phase 2 Completed
150 enrolled
GenitourinaryGynecologic

Ovarian Neoplasms, Peripheral Nervous System Diseases, Prostatic Neoplasms

NCT01526564 2013-11-11

Clinical Study on Acetyl-L-Carnitine

Lee's Pharmaceutical Limited

Phase 3 Completed
239 enrolled

Peripheral Sensory Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡